Aftertrade Broking Pvt Ltd ("Manager to the Offer") has informed BSE regarding Intimation of Identified Date for the Proposed Open Offer of Aspira Pathlab & Diagnostics Ltd ('Target Company') ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts more than Nifty Microcap 250 and 7.2 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Aftertrade Broking Pvt Ltd, the manager to the offer, has informed BSE that the identified date for the proposed open offer of Aspira Pathlab & Diagnostics Ltd has been fixed as 27/03/2026. The offer is for 26,76,180 equity shares at ₹55 per share, representing 26% of the fully paid-up equity share capital. The offer is being made by five acquirers — Mr. Arvind Karsandas Bhanushali, Mrs. Deepali Arvind Bhanushali, Mr. Jay Arvind Bhanushali, Mr. Nikunj Velji Mange, and Mr. Raj Arvind Bhanushali — along with Mrs. Shraddha Nikunj Mange as Person Acting in Concert (PAC). The identified date is used to determine which public shareholders will receive the Letter of Offer. The public announcement was made on 26/09/2025 and the draft letter of offer was filed on 13/10/2025.
Shareholders of record as on 27/03/2026 will be eligible to receive the Letter of Offer and tender their shares in the open offer at ₹55 per share. This is a significant 26% open offer by the Bhanushali group, indicating a meaningful increase in their stake in the company, which may affect the stock price and trading volumes around the identified date.